Target intelligence / Profile preview

Superoxide dismutase 2 pseudogene 1 (SOD2P1)

Target: SOD2P1
Molecular classification: Other

Overview

Superoxide dismutase 2 pseudogene 1 (SOD2P1) is a non-functional DNA sequence in humans that closely resembles the mitochondrial superoxide dismutase 2 (SOD2) gene, but does not encode an active protein. Pseudogenes arise through gene duplication or retrotransposition events, and though they share sequence similarity with their functional counterparts, mutations or loss of regulatory sequences render them inactive. SOD2P1 does not catalyze the conversion of superoxide radicals, nor does it participate in mitochondrial oxidative stress management. Its biological relevance, if any, is limited to possible indirect regulatory roles—there are currently no recognized clinical or therapeutic implications for SOD2P1 specifically.

Other names: SOD2P1Superoxide dismutase 2, mitochondrial pseudogene 1Superoxide dismutase 2 pseudogene 1

Mechanism of action

None for SOD2P1 (MOA entries only apply to functional proteins or therapeutic targets.)

Biological functions

None directly (for the pseudogene itself). Pseudogenes can sometimes regulate their parent gene indirectly via mechanisms such as competitive endogenous RNA (ceRNA), but no biological activity is documented for SOD2P1 specifically. In rare cases, pseudogenes can affect gene networks via RNA transcripts or sequence exchange, but this is not established for SOD2P1.

Disease associations

Other (General pseudogene context includes regulatory effects in cancer, but specific disease association for SOD2P1 is not documented.)

Safety considerations

None documented (Pseudogenes are usually not associated with notable safety or therapeutic challenges.)

Interacting drugs

None (No drugs are known to interact with SOD2P1; pseudogenes do not encode proteins targeted by therapeutics.)

Biomarkers

None established (General pseudogene RNA can sometimes serve as biomarkers, but SOD2P1 is not cited as such.)

Beyond the preview

Go deeper on Superoxide dismutase 2 pseudogene 1 (SOD2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Superoxide dismutase 2 pseudogene 1 (SOD2P1).

Explore the full profile